Filtered By:
Specialty: Pharmaceuticals
Management: Insurers
This page shows you your search results in order of date.
Order by Relevance | Date
Total 41 results found since Jan 2013.
Will The Government Set Price Controls For Covid-19 Vaccines?
With the government no longer in the Covid-19 business, payment for these vaccines has now been passed on to insurers as happens with all vaccines.
Source: Forbes.com Healthcare News - January 13, 2023 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma Source Type: news
Omicron Resists Pfizer Vaccine but Causes Less Severe Disease
TUESDAY, Dec. 14, 2021 -- Compared with previous coronavirus variants, omicron appears to cause less severe illness, but is more resistant to the Pfizer vaccine, researchers at South Africa ' s largest health insurer report.
The team at Discovery...
Source: Drugs.com - Pharma News - December 14, 2021 Category: Pharmaceuticals Source Type: news
The Cost Of Being Unvaccinated Just Went Up — Most Insurers Are Passing Costs Back To Patients As Covid Hospitalizations Soar
The majority of private health insurers are no longer waiving out-of-pocket costs for Covid-19 treatment and are passing these back to patients, according to research by KFF, and almost no provider will still be eating the cost by the end of the year.
Source: Forbes.com Healthcare News - August 19, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Policy /policy Innovation /innovation Healthcare /healthcare Breaking breaking-news Editors' Pick editors-pick Coronavirus Source Type: news
InnovationRx: Health Insurer Profits; Plus 200 Million Vaccinations
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - April 21, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Coronavirus Source Type: news
Patients Can ’t Be Charged Fees For A Covid-19 Vaccine — Including An ‘Administration Fee’
People are taking to social media to say that their insurance companies have charged illegal fees for “vaccine administration.”
Source: Forbes.com Healthcare News - April 19, 2021 Category: Pharmaceuticals Authors: Leah Rosenbaum, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Science /science Coronavirus Source Type: news
Patients Can ’t Be Charged Fees For A Covid-19 Vaccine — Here’s What To Do If You Got Billed For It
People are taking to social media to say that their insurance companies have charged illegal fees for “vaccine administration.”
Source: Forbes.com Healthcare News - April 19, 2021 Category: Pharmaceuticals Authors: Leah Rosenbaum, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Science /science Coronavirus Source Type: news
Clover Health Hit By Rising Covid-19 Costs In Fourth Quarter
The Medicare Advantage insurer is looking to expand into direct contracting as a way to boost its business in 2021, but is waiting for federal approval.
Source: Forbes.com Healthcare News - March 2, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Business /business Editors' Pick editors-pick Coronavirus Decision Maker Content decisionmaker Source Type: news
Molina Latest Health Insurer Hit By Rising Covid-19 Costs
Molina Healthcare ’s profits dipped in the fourth quarter and for the full year of 2020 as the Covid-19 pandemic triggered rising expenses and an uptick in medical claims for the health insurer.
Source: Forbes.com Healthcare News - February 10, 2021 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Editors' Pick editors-pick Coronavirus Decision Maker Content decisionmaker pharma Source Type: news
Humana Hit Hard By Covid-19 Costs As Medicare Advantage Enrollment Rises
Humana reported a $458 million fourth quarter loss as the health insurer was hit by costs related to the Covid-19 pandemic and the expense of testing and treating these patients in the last two months of 2020.
Source: Forbes.com Healthcare News - February 3, 2021 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Editors' Pick editors-pick Coronavirus Decision Maker Content decisionmaker pharma Source Type: news
SFBT Thursday Digest: Rescuing Covid vaccines, 'megaregion' rail plan
Good morning, Bay Area. Here's the latest news on this dark and stormy Thursday morning.
Blue Shield to the rescue?: California will turn over its coronavirus vaccine distribution to private health insurance company Blue Shield in hopes of accelerating its snail-paced rollout. The California Department of Public Health said Wednesday that the transition to the Oakland-based health pro vider will take place over the next few weeks. The state has yet to announce how it selected Blue Shield or how much…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 28, 2021 Category: Pharmaceuticals Authors: Ted Andersen Source Type: news
Most Health Insurers Are Waiving Covid-19 Costs For Consumers, New Analysis Shows
Many Americans may be experiencing a phenomenon rarely associated with the health insurance industry: generosity.
Source: Forbes.com Healthcare News - November 24, 2020 Category: Pharmaceuticals Authors: Deb Gordon, Contributor Tags: Healthcare /healthcare Innovation /innovation Money /money Banking & Insurance /banking-insurance Coronavirus Source Type: news
Startup Doc.ai Inks Deal With Health Insurer Anthem, Names Female Cofounder CEO
The deal is worth $100 million over five years, according to CEO Sam De Brouwer, who is focused on scaling up doc.ai ’s enterprise offerings.
Source: Forbes.com Healthcare News - September 29, 2020 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Enterprise Tech /enterprise-tech Cybersecurity /cybersecurity Editors' Pick editors-pick Coronavirus Source Type: news
Cigna Profits Rise As Patients Delay Treatment In Pandemic
Cigna is the latest health insurer to report a big boost in second-quarter profits as its health plan members postpone treatment during the spread of the Coronavirus strain Covid-19.
Source: Forbes.com Healthcare News - July 30, 2020 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Consumer Tech /consumer-tech Editors' Pick editors-pick business pharma Source Type: news
Anthem Blue Cross Profits Soar As Patients Postpone Care In Pandemic
Anthem ’s profits doubled to more than $2 billion in the second quarter as elective procedures the large health insurer pays for delayed amid the spread of the Coronavirus strain Covid-19.
Source: Forbes.com Healthcare News - July 29, 2020 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Enterprise Tech /enterprise-tech Editors' Pick editors-pick Coronavirus business pharma Source Type: news
Pandemic Boosts Centene ’s Medicaid Enrollment And Profits
Health insurer Centene is seeing a boost in Medicaid enrollment as unemployment rises amid the spread of the coronavirus strain COVID-19 though Americans are signing up to such coverage at a slower pace than the company originally thought.
Source: Forbes.com Healthcare News - July 28, 2020 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Consumer Tech /consumer-tech Money /money Markets /markets Editors' Pick editors-pick Coronavirus business pharma Source Type: news
